Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane within oral biofilms is a critical target for antimicrobial strategies. It acts as a selective barrier and is essential for cell viability. Targeting the membrane with agents like chlorhexidine or through surface modification with polymers can disrupt its integrity, leading to cell death or altered function. The composition and properties of the membrane vary between bacterial species, and the EPS matrix of the biofilm can protect the membrane from external stressors. Strategies involving polymers aim either to enhance protection of the membrane (e.g., for probiotics) or to disrupt it more effectively in pathogenic bacteria.
Disruption of membrane integrity; interference with membrane protein function; inhibition of cell wall synthesis; alteration of membrane permeability
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Cell Membrane (Oral Biofilm) (BCM (Oral Biofilm)).